Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $7.25 and traded as low as $6.52. Nxera Pharma shares last traded at $6.52, with a volume of 200 shares changing hands.
Nxera Pharma Price Performance
The stock has a fifty day simple moving average of $7.22 and a two-hundred day simple moving average of $8.57.
About Nxera Pharma
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Recommended Stories
- Five stocks we like better than Nxera Pharma
- Why Are Stock Sectors Important to Successful Investing?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is the Australian Securities Exchange (ASX)
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
